Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN

Tevogen Bio Holdings (TVGN) Income Statement

30 Followers

Tevogen Bio Holdings Income Statement

Last quarter (Q1 2024), Tevogen Bio Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, Tevogen Bio Holdings's net income was $10.51M. See Tevogen Bio Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
---$ 0.00
Cost of Revenue
----
Gross Profit
----
Operating Expense
$ 30.83M$ 2.27M$ 953.08K$ 181.42K
Operating Income
$ -30.83M$ -2.27M$ -953.08K$ -181.42K
Net Non Operating Interest Income Expense
$ 2.24M$ -256.03K$ 4.95M-
Other Income Expense
$ 802.71K$ -2.46M$ -5.36M$ 152.68K
Pretax Income
$ -26.13M$ -67.33K$ 4.41M$ -28.75K
Tax Provision
----
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ 14.08M$ -67.33K$ 4.41M$ -28.75K
Basic EPS
$ 0.19-$ 0.18-
Diluted EPS
$ -0.15-$ 0.18-
Basic Average Shares
$ 192.95M$ 18.77M$ 47.93M-
Diluted Average Shares
$ 198.00M$ 18.77M$ 47.93M-
Dividend Per Share
$ 1.00K---
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 30.83M$ 2.27M$ 953.08K$ 181.42K
Net Income From Continuing And Discontinued Operation
$ 14.84M$ -67.33K$ 4.41M$ -28.75K
Normalized Income
$ 1.67M$ -53.19K$ 3.48M$ -181.42K
Interest Expense
----
EBIT
$ 12.16M$ 188.71K$ 4.41M$ -181.42K
EBITDA
$ 12.26M$ 188.71K$ 4.41M$ -181.42K
Currency in USD

Tevogen Bio Holdings Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis